Regulatory T cells as therapeutic targets and mediators.


Journal

International reviews of immunology
ISSN: 1563-5244
Titre abrégé: Int Rev Immunol
Pays: England
ID NLM: 8712260

Informations de publication

Date de publication:
2019
Historique:
pubmed: 4 6 2019
medline: 20 2 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

With the advent of the concept of dominant tolerance and the subsequent discovery of CD4

Identifiants

pubmed: 31154878
doi: 10.1080/08830185.2019.1621310
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-203

Auteurs

Amit Sharma (A)

Academy of Immunology and Microbiology, Institute for Basic Science (IBS) , Pohang , Republic of Korea.
Division of Integrative Biosciences & Biotechnology, Pohang University of Science and Technology (POSTECH) , Pohang , Republic of Korea.

Dipayan Rudra (D)

Academy of Immunology and Microbiology, Institute for Basic Science (IBS) , Pohang , Republic of Korea.
Division of Integrative Biosciences & Biotechnology, Pohang University of Science and Technology (POSTECH) , Pohang , Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH